Your browser doesn't support javascript.
loading
Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer.
Melling, Nathaniel; Taskin, Berivan; Hube-Magg, Claudia; Kluth, Martina; Minner, Sarah; Koop, Christina; Grob, Tobias; Graefen, Markus; Heinzer, Hans; Tsourlakis, Maria Christina; Izbicki, Jakob; Wittmer, Corinna; Huland, Hartwig; Simon, Ronald; Wilczak, Waldemar; Sauter, Guido; Steurer, Stefan; Schlomm, Thorsten; Krech, Till.
Afiliação
  • Melling N; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany.
  • Taskin B; General, Visceral and Thoracic Surgery Department and Clinic, University Medical Center Hamburg-Eppendorf, Germany.
  • Hube-Magg C; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany.
  • Kluth M; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany.
  • Minner S; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany.
  • Koop C; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany.
  • Grob T; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany.
  • Graefen M; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany.
  • Heinzer H; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Germany.
  • Tsourlakis MC; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Germany.
  • Izbicki J; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany.
  • Wittmer C; General, Visceral and Thoracic Surgery Department and Clinic, University Medical Center Hamburg-Eppendorf, Germany.
  • Huland H; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany.
  • Simon R; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Germany.
  • Wilczak W; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany.
  • Sauter G; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany.
  • Steurer S; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany.
  • Schlomm T; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany.
  • Krech T; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Germany.
Prostate ; 76(3): 259-72, 2016 Feb 15.
Article em En | MEDLINE | ID: mdl-26764246

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Citoplasma / Instabilidade Genômica / Proteína Semelhante a ELAV 1 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: Prostate Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Citoplasma / Instabilidade Genômica / Proteína Semelhante a ELAV 1 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: Prostate Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha